ZMYND8 and neoplasm: Previous studies revealed that ZMYND8 and ZMYND11 might act as either transcriptional activators or repressors, and both proteins harbor tumor suppressor functions, particularly in breast, prostate, colon, and ovarian carcinoma [51,52].